A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers

Clinical trial NCT07143331 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07143331
Sponsor: Klotho Sciences Australia Pty Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants Alzheimer Disease Chronic Kidney Disease

Start date: 2025-08-30
Primary completion: 2026-04-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.